T1	intervention 23 32	letrozole
T2	control 40 49	tamoxifen
T6	location 265 282	Basel Switzerland
T7	location 358 372	Turku, Finland
T8	age 408 417	<70 years
T9	age 430 441	>/=70 years
T10	total-participants 493 511	Nine hundred seven
T12	iv-bin-percent 1113 1116	38%
T13	cv-bin-percent 1159 1162	18%
T17	iv-bin-percent 1271 1274	26%
T18	cv-bin-percent 1287 1290	22%
T19	outcome 1293 1296	TTP
T20	iv-cont-median 1406 1416	8.8 months
T21	cv-cont-median 1429 1439	6.0 months
T22	outcome 1375 1382	younger
T23	outcome 1441 1446	older
T24	iv-cont-median 1470 1481	12.2 months
T25	cv-cont-median 1494 1504	5.8 months
T3	eligibility 512 548	patients with advanced breast cancer
T5	outcome 1018 1029	overall ORR
T11	outcome 1221 1225	ORRs
T14	outcome 1599 1602	ORR
